Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Carcinoma:Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02449135
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:30.626052+00:00
Published At
2021-09-09T00:00:00+00:00
Record Updated At
2021-09-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-09"
protocolSection.identificationModule.nctId
"NCT02449135"
protocolSection.identificationModule.officialTitle
"Nano Drug Interventional Therapy Using Digital Subtraction Angiography\uff08DSA\uff09 for Pancreatic Carcinoma\uff1aClinical Trial"
protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.